{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:05:24Z","timestamp":1787169924956,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim of the study was to develop a simple prediction model based on previous treatment plans for head-and-neck cancer (HNC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This study was conducted on 95 patients who underwent volumetric-modulated arc therapy (VMAT) with curative intent for HNC at our institute between January 2016 and December 2022 with intact bilateral parotid glands. Two simple prediction models were used: one linear regression model and one exponential model. Both models use fractional overlapping parotid volume with planning target volume (PTV) as a predictor of mean parotid dose. The fractional overlapping volume was calculated as the difference between the volume of the parotid gland minus the volume of the parotid gland outside the PTV plus a 2 mm margin, divided by the volume of the parotid gland. Statistical calculations were done using data analysis tools and Solver in Microsoft Excel (Microsoft Office 2013, Redmond, WA, USA). To enhance the accuracy of the results, outliers were excluded with residuals &gt;2 standard deviations below and above the residuals.\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      and root-mean-square error were calculated for both models to evaluate the quality of the predictions. The normality of both models\u2019 residuals was validated using the Shapiro\u2013Wilk test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Both linear and exponential prediction models exhibited strong correlation statistics, with\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0.85 and 0.82, respectively. The authors found a fractional overlap of 16.4% and 18.9% in linear and exponential models that predict parotid mean dose 26 Gy. The implementation was carried out on a cohort of 12 prospective patients, demonstrating a remarkable improvement in minimizing the dose to the parotid glands.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In this single-institutional study, the authors successfully developed a prediction model for mean parotid dose in HNC patients undergoing radiotherapy. The model showed promising accuracy and has the potential to assist planners in optimizing treatment plans and minimizing radiation-related toxicity. It is possible to avoid under sparing the organs at risks in some cases and wasting time or effort on physically impossible goals in others using this prediction model. As a result, planning resources can be used much more efficiently. Future studies should focus on validating the model\u2019s performance using external datasets and exploring its integration into clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmp.jmp_52_23","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T09:01:34Z","timestamp":1695200494000},"page":"274-280","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Development of Prediction Model for Mean Parotid Dose of HNC Undergoing Radiotherapy - A Single Institutional Study"],"prefix":"10.4103","volume":"48","author":[{"given":"Soumen","family":"Bera","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Ruby General Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ruby General Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjoy","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ruby General Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ruby General Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ruby General Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"R1-20240906","doi-asserted-by":"crossref","first-page":"e0009","DOI":"10.5041\/RMMJ.10143","article-title":"Head and neck cancers in developing countries","volume":"5","author":"Joshi","year":"2014","journal-title":"Rambam Maimonides Med J"},{"key":"R3-20240906","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5005\/jp-journals-10001-1132","article-title":"Head and neck cancer burden in India","volume":"4","author":"Kulkarni","year":"2013","journal-title":"Int J Head and Neck Surg"},{"key":"R4-20240906","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-20240906","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0360-3016(99)00247-3","article-title":"Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer","volume":"45","author":"Eisbruch","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-20240906","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijrobp.2010.11.030","article-title":"Experience-based quality control of clinical intensity-modulated radiotherapy planning","volume":"81","author":"Moore","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20240906","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2006.05.028","article-title":"Geometric factors influencing dosimetric sparing of the parotid glands using IMRT","volume":"66","author":"Hunt","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20240906","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/acm2.12203","article-title":"A model for predicting the dose to the parotid glands based on their relative overlapping with planning target volumes during helical radiotherapy","volume":"19","author":"Millunchick","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"R9-20240906","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4103\/jcrt.JCRT_362_16","article-title":"Astudy on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas","volume":"14","author":"Bandlamudi","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"R10-20240906","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.1016\/j.ijrobp.2007.07.1648","article-title":"The predictive value of degree of PTV-OAR overlap on achieving parotid dose constraints in head and neck simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT)","volume":"69","author":"Yaparpalvi","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20240906","doi-asserted-by":"crossref","first-page":"121704","DOI":"10.1118\/1.4828788","article-title":"Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: An intertechnique and interinstitutional study","volume":"40","author":"Lian","year":"2013","journal-title":"Med Phys"},{"key":"R12-20240906","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.meddos.2015.01.002","article-title":"Simple tool for prediction of parotid gland sparing in intensity-modulated radiation therapy","volume":"40","author":"Gensheimer","year":"2015","journal-title":"Med Dosim"},{"key":"R13-20240906","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.meddos.2021.02.003","article-title":"Mean parotid dose prediction model using machine learning regression method for intensity-modulated radiotherapy in head and neck cancer","volume":"46","author":"Ranjith","year":"2021","journal-title":"Med Dosim"},{"key":"R14-20240906","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1118\/1.4761864","article-title":"Predicting dose-volume histograms for organs-at-risk in IMRT planning","volume":"39","author":"Appenzoller","year":"2012","journal-title":"Med Phys"},{"key":"R16-20240906","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"key":"R17-20240906","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"issue":"Suppl","key":"R19-20240906","article-title":"Intensity-Modulated Radiation Therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC): Toxicities and Efficacy. I","volume":"69","author":"Diaz","year":"2007","journal-title":"J. Radiation Oncology, Biology, Physics"},{"key":"R20-20240906","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"Aprospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_52_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:15:05Z","timestamp":1787166905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_52_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jmp.jmp_52_23","relation":{},"ISSN":["0971-6203","1998-3913"],"issn-type":[{"value":"0971-6203","type":"print"},{"value":"1998-3913","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-04-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}